Atomizer used with Narcan subject of recall notice
Telefex Medical, manufacturer of the MAD300 Intranasal Mucosal Atomization device used as part of the Naloxone delivery system, has issued a recall notification.
Naloxone is the generic name for Narcan, the opioid overdose reversal drug.
The product is used by opioid overdose prevention programs across New York state, including those in the Hudson Valley.
Some 1,600 people have been trained to use Narcan through the Dutchess County Medical Examiner’s Office and its “train-the-trainer” program.
Approximately one-third of the kits distributed are estimated to be affected by the recall.
Individuals who have a Narcan kit are advised to check the lot number on the device carton and register to receive a replacement kit when available.
In the event of an overdose, continue to use the Narcan kit, even if it is affected by the recall and call 911 immediately to have help on the way if the atomizer is not working at maximum capacity and to use the kits as trained, administering a second dose if the individual is not revived.
“It is important to stress that the Naloxone medication inside the kit is safe and can work to reverse an overdose,” Deputy Medical Examiner Dr. Kia Newman said.